Kaarin M. Slotte
FDA investigator
Appears on 1 document from 2024, mostly at sites in Washington. Most often cites testing and approval or rejection of components, drug product containers, and closures (21 CFR 211.84(d)(1)).
- 1
- Documents on file
- 1.0
- Observations per 483
- 2024
- First seen
- 2024
- Most recent
What they cite most
From 1 observations- 21 CFR 211.84(d)(1)Testing and approval or rejection of components, drug product containers, and closures1
Activity by year
2024: 1
Where
Washington 1
Often inspects with
Is Kaarin M. Slotte coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-05-03 | 483 BloodworksMay 3, 2024 · Seattle, Washington | Seattle, Washington | 1 |
About this profile
What does Kaarin M. Slotte inspect?
Kaarin M. Slotte appears on 1 document on file covering 1 site, mostly in Washington.
What do they cite most often?
21 CFR 211.84(d)(1) (testing and approval or rejection of components, drug product containers, and closures).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Kaarin M. Slotte is dated May 3, 2024.